Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease

Diabetes

Volumn 46, Issue 2, 1997, Pages 237-243

  Kallmann, Boris A ^a,c   Hüther, Manfred ^a   Tubes, Monika ^a   Feldkamp, Joachim ^a   Bertrams, Jörg ^b   Gries, Friedrich A ^a   Lampeter, Eberhard F ^a   Kolb, Hubert ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ELISABETH KRANKENHAUS ESSEN   (Germany)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; HLA DQ ANTIGEN; INSULIN; INSULIN ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; PANCREAS ISLET CELL ANTIBODY; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE;

EID: 1842404766     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.237     Document Type: Article

References (51)

1. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
2. Del Prete GF, De Carli M, Ricci M, Romagnani S: Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88:346-350, 1991
3. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-251, 1994
4. Scott P: IL-12 initiation cytokine for cell-mediated immunity. Science 260:496-497, 1993
5. Mosmann TR, Moore KW: The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol Today 12:A49-A53, 1991
6. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
7. Decarli M, Delios MM, Zancuoghi G, Romagnani S, Delprete G: Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18:301-308, 1994
8. Simon KA, Seipelt E, Sieper J: Divergent T cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 91:8562-8566, 1994
9. Del Prete GF, Tiri A, Mariotti S, Pinchera A, Ricci M, Romagnani S: Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin Exp Immunol 69:323-331, 1987
10. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Poser S: Tumor necrosis factor-alpha mRNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37:82-88, 1995
11. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL: Overexpression of IL-10 in atopic dermatitis. J Immunol 154:1956-1963, 1995
12. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43:613-621, 1994
13. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H: Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ, but not of interleukin-4. Diabetologia 37:1154-1158, 1994
14. Shehadeh NN, LaRosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300, 1993
15. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188, 1995
16. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: IL-4 reverses T-cell proliferative unreponsiveness and prevents the onset of diabetes in NOD mice. J Exp Med 178:87-99, 1993
17. Pennline KJ, Roque-Gaffney E, Monahan M: Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 71:169-175, 1994
18. Foulis AK, McGill M, Farquharson MA: Insulitis in type 1 (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes and Interferon-γ containing cells. J Pathol 164:97-103, 1991
19. Weiss U, Manfras BJ, Terjung D, Eiermann T, Wolpl A, Loliger C, Kuhnl P, Boehm BO: In vitro stimulation with glutamic acid decarboxylase (GAD65) leads to an oligoclonal response of peripheral T-cells in an IDDM patient Scand J Immunol 42:673-678, 1995
20. Chang JC, Linarelli LG, Laxer JA, Froning KJ, Caralli LL, Brostoff SW, Carlo DJ: Insulin-secretory-granule specific T cell clones in human IDDM. J Autoimmun 8:221-234, 1995
21. Weetman AP, McGregor AM: Autoimmune thyroid disease: developments in our understanding. Endocr Rev 5:309-355, 1984
22. Burman KD, Baker JR: Immune mechanisms in Graves' disease. Endocr Rev 6:183-232, 1985
23. Mullins RJ, Cohen SB, Webb LM, Chernajovsky Y, Dayan CM, Londei M, Feldmann M: Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines. J Clin Invest 96:30-37, 1995
24. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
25. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark Å: A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase anibodies in childhood IDDM. Diabetologia 37:344-350, 1994
26. Böhmer K, Keilacker H, Kuglin B, Hübinger A, Bertrams J, Gries FA, Kolb H: Proinsulin autoantibodies are more closely associated with type I (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia 34:830-834, 1991
27. Olerup O, Aldener A, Fogdell A: HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41:119-134, 1993
28. Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Sveigaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 44:1-18, 1994
29. Zangerle PF, De Groote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P: Direct stimulation of cytokines (TL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4:568-575, 1992
30. Zhang J, Markovic Plese S, Lacet B, Raus J, Weiner HL, Hafler DA: Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179:973-984, 1994
31. Bentwich Z, Kalinkovich A, Weisman Z: Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16:187-191, 1995
32. Ciampolillo A, Guastamacchia E, Caragiulo L, Lollino G, De Robertis O, Lattanzi V, Giorgino R: In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients. Diabetes Res Clin Pract 21:87-93, 1993
33. Sachs JA, Whichelow CE, Hitman GA Niven M, Thode H, Meager A: The effect of HLA and insulin-dependent diabetes mellitus on the secretion levels of tumour necrosis factors alpha and beta and gamma interferon. Scand J Immunol 32:703-708, 1990
34. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Bandrihaye M, Delacroix D, Franchimont P: Direct stimulation of cytokines (TL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4:239-248, 1992
35. Loos H, Blok Schut B, van Doom R, Hoksbergen R, Brutel de la Riviere A, Meerhof L: A method for the recognition and separation of human blood monocytes on density gradients. Blood 48:731-742, 1976
36. Petrovsky N, McNair P, Harrison LC: Circadian rhythmicity of interferon-gamma production in antigen-stimulated whole blood. Chronobiologia 21:293-300, 1994
37. Nicoletti F, Scalia G, Condorelli F, Stivala A, Leonardi C, Mattina A, Steinsvag PO, La Rosa L, Lunetta M: Anti-cytomegalovirus IgM and IgG antibodies, islet cell antibodies and gamma Interferon serum levels in newly diagnosed IDDM patients. Int J Immunopath Pharmacol 4:99-106, 1991
38. Cavallo MG, Pozzilli P, Bird C, Wadhwa M, Meager A, Visalli N, Gearing AJ, Andreani D, Thorpe R: Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 86:256-259, 1991
39. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diahetologia 39:60-69, 1996
40. Böhmer KP, Kolb H, Kuglin B, Zielasek J, Hübinger A, Lampeter EF, Weber B, Kolb-Bachofen V, Jastram HU, Bertrams J, Gries FA: Linear loss of insulin secretory capacity during the last six months preceding IDDM: no effect of antiedematous therapy with ketotifen. Diabetes Care 17:138-141, 1994
41. Bocci V: Interleukins: clinical pharmacokinetics and practical implications. Clin Pharmacokinet 21:274-284, 1991
42. MacKenzie WA, Schwartz AE, Friedman EW, Davies TF: Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 64:818-824, 1987
43. Del Prete GF, Tiri A, De Carli M, Mariotti S, Pinchera A, Chretien I, Romagnani S, Ricci M: High potential to tumor necrosis factor-α (TNF-α) production of thyroid-infiltrating T lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity. Autoimmunity 4:267-272, 1989
44. Watson PF, Pickerill AP, Davies R, Weetman AP: Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 79:355-360, 1994
45. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
46. Rizzo LV, DeKruyff RH, Umetsu DT: Generation of B cell memory and affinity maturation: induction with Th1 and Th2 T cell clones. J Immunol 148:3733-3739, 1992
47. Couper JJ, Harrison LC, Aldis JJE, Colman PG, Ferrante A: IgG subclass antibodies to glutamic acid decarboxylase: markers of immune regulatory balance and disease risk in insulin-dependent diabetes (Abstract). Autoimmunity 21-A114, 1995
48. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987
49. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A: Inheritance of MHC class II genes in IDDM studied in population-based affected and control families. Diabetologia 37:1105-1112, 1994
50. Murray JS, Madri J, Pasqualini T, Bottomly K: Functional CD4 T cell subset interplay in an intact immune system. J Immunol 150:4270-4276, 1993
51. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D: A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73-83, 1994